Better Coronavirus Stock: Gilead Sciences or Novavax?
Many investors have eagerly followed the fast-paced achievements of companies developing COVID-19 treatments and vaccines. Gilead Sciences (NASDAQ: GILD) and Novavax (NASDAQ: NVAX) are two of the companies at the forefront of these efforts.
Both biotech stocks have been winners so far in 2020. But Novavax's year-to-date gain of more than 1,200% makes Gilead's 15% gain look tiny by comparison. Which coronavirus-focused stock is the better pick for long-term investors? Here's how Gilead and Novavax compare.
Image source: Getty Images.
Source Fool.com
